DOSSIER · UPDATED 18 NOV 2025

Frontier Medicines

Frontier Medicines’is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to discover and…

frontiermeds.com ↗Claim this profile
Founded
2018
Headcount
117
Open roles
0
Last raised
Series C · $20M
SECTION I · THE BRIEF

Inside Frontier Medicines

Brief #65641Updated 18 NOV 2025SOUTH SAN FRANCISCOMEDICAL ORGANIZATIONSSERIES C
Employbl Dossier

Frontier Medicines

Frontier Medicines’is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to…

Founded
2018
Headcount
117
Open roles
0
Last raised
Series C · $20M
Section II — RestrictedMembers only
  • Tech stack (Frontier Medicines engineering primaries)
  • Hiring focus this quarter
  • Interview format & rubric
  • Comp bands by level
  • Decision-makers in talent
  • Recent news & moves
Open Frontier Medicines briefSign in

7-day free trial · $25/mo · cancel anytime

TAGS

Categorized in

Company Collections

These are collections Frontier Medicines is a part of. Click on the collection name to view similar companies.

Frontier Medicines' Industries

Frontier Medicines' Tech Stack

LOCATIONS

Where they work

Frontier Medicines Headquarters Location

151 Oyster Point Blvd Second Floor, South San Francisco, CA, 94080

Loading map…
FUNDING

Capital raised

Total Amount Raised: $255,500,000

Frontier Medicines Funding Rounds

  • Series C

    $20,000,000

  • Series C

    $20,000,000

    Series C Investors

    ArrowMark Colorado Holdings
    Deep Track Capital

  • Series C

    $80,000,000

  • Series C

    $80,000,000

    Series C Investors

    Deerfield Management
    Droia Ventures
    DCVC Bio
    Galapagos
    RA Capital Management
    MPM Capital

  • Series B

    $88,500,000

  • Series B

    $88,500,000

    Series B Investors

    RA Capital Management
    Woodline Partners
    MPM Capital
    Deerfield Management
    ArrowMark Colorado Holdings
    Deep Track Capital
    Droia Ventures
    DCVC Bio
    Sphera Global Healthcare Fund
    Driehaus Capital Management

  • Series A

    $67,000,000

  • Series A

    $67,000,000

    Series A Investors

    Deerfield Management
    Droia Ventures
    MPM Capital
    RA Capital Management
    DCVC Bio
    Berkeley Catalyst Fund
Funding info provided by Diffbot.
EMPLOYEE REVIEWS

On the ground at Frontier Medicines

Frontier Medicines Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Frontier Medicines.

Recent reviews